Leveraging ctDNA to Assess Treatment Response and Determine Relapse Risk in Patients Receiving Definitive Treatment for Hepatobiliary Cancer
Details
Status
Open: Currently recruiting participants.
Closed: Recruitment either has not started or has paused or completed.
open
Study Type
Interventional (clinical trials): Test treatments.
Observational: Conduct surveys and interviews, study medical records and otherwise observe people or groups over time.
Other
Study Phase
Each study phase tests different aspects of the medication or treatment:
- Phase I: safety and dosing
- Phase II: effectiveness and side effects
- Phase III: efficacy compared to standard treatments
- Phase IV: long-term safety after approval for use
Unspecified
Location(s)
Johns Hopkins study sites. Additional study locations may be found on ClinicalTrials.gov.
The Johns Hopkins Hospital
1800 Orleans St Baltimore, MD 21287
Contact Us
(410) 955-8964Eligibility
- Presence of resectable Stage I-IV cholangiocarinoma or Stage I-VI hepatocellular carcinoma
- Pathology consistent with cholangiocarcinoma/hepatocellular carcinoma